Training device and patient onboarding company Noble International, which was acquired by Aptar Pharma in October 2019, has announced the appointment of Jeffrey Miller as Director, Business Development. The company manufactures training devices that mimic marketed MDIs and DPIs that can simulate actuation force and provide feedback for guiding and correcting … [Read more...] about Noble International names Jeffrey Miller as Director, Business Development
News
Seurat reports data from preclinical studies of intranasal IGF-1
Seurat Therapeutics has published data from studies of its intranasal IGF-1 in rat models for the treatment of migraine in the journal Brain Research. The studies were conducted at the University of Chicago, which has licensed patents for the use of nasal IGF-1 to treat migraines to Seurat. According to the article, the formulation demonstrated the potential of … [Read more...] about Seurat reports data from preclinical studies of intranasal IGF-1
Vectura names Sharon Johnson as Executive VP for Delivery Management
Vectura has announced the appointment of Sharon Johnson to the newly created position of Executive VP for Delivery Management "to support innovation, customer focus and growth as the company continues with its strategic development as a leading inhalation specialist in the pharmaceutical services space." Johnson was most recently Senior VP, Global Quality and … [Read more...] about Vectura names Sharon Johnson as Executive VP for Delivery Management
Nanoform adds US subsidiary
Nanoform, a specialist in nanonization technology, has announced the establishment of a wholly owned US subsidiary, citing growing demand for its technology from US pharma companies. Nanoform recently announced the appointment of former Catalent executive Sally Langa as its new Head of US Sales. In November 2019, Nanoform won the 2019 Excellence in Pharma: … [Read more...] about Nanoform adds US subsidiary
Apollo Global Management agrees to acquire Covis Pharma
Apollo Global Management has agreed to acquire Covis Pharma, which markets several ciclesonide aerosol products: the Alvesco MDI and Omnaris and Zetonna nasal sprays. Terms of the deal were not disclosed. Covis is currently owned by Cerberus Capital Management, which founded the company in 2011. In 2017, Covis acquired the US rights to the three ciclesonide … [Read more...] about Apollo Global Management agrees to acquire Covis Pharma
Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award
Boehringer Ingelheim's reusable Respimat soft mist inhaler has won the 2020 Pharmapack Eco-Design Award, the company said. As many as six medication cartridges can be used with this version of the Respimat before the device must be replaced, significantly reducing the amount of plastic waste. According to the company, the reusable Respimat is expected to save 776 … [Read more...] about Boehringer Ingelheim’s reusable Respimat SMI wins 2020 Pharmapack eco-design award
Timm Crowder named Chief Operating Officer of Aerami Therapeutics
Inhaled insulin developer Aerami Therapeutics (formerly Dance Biopharm) has announced the appointment of Timm Crowder as Chief Operating Officer. Crowder, who was most recently Chief Operating Officer of Spyryx Biosciences, was a co-founder of DPI developer Oriel Therapeutics. Following Oriel's acquisition by Sandoz in 2010, Crowder held a series of manufacturing … [Read more...] about Timm Crowder named Chief Operating Officer of Aerami Therapeutics
Nemera’s Safe’n’Spray wins Pharmapack 2020 innovation award
Drug delivery device maker Nemera said that its Safe’n’Spray concept intranasal device has won the "Best Innovation In Drug Delivery Device" Award at Pharmapack. In addition to being a connected device that allows for usage monitoring and analysis, the Safe’n’Spray utilizes electronic fingerprint identification and locking to control dosing of potent drugs, with the … [Read more...] about Nemera’s Safe’n’Spray wins Pharmapack 2020 innovation award
Koura announces clinical trial plans for Zephex 152a
Koura (formerly Mexichem Fluor) announced that the FDA has cleared the company's IND for Zephex HFA 152a MDI propellant, and the company plans to initiate clinical trials of the propellant this month. In December 2019, Chiesi announced that it intended to bring a Zephex 152a inhaler to market by the end of 2025. At DDL 2016, Koura presented data suggesting the … [Read more...] about Koura announces clinical trial plans for Zephex 152a
Verona Pharma appoints David Zaccardelli as President and CEO
Verona Pharma has announced the appointment of former United Therapeutics executive David Zaccardelli as President and CEO, succeeding Jan-Anders Karlsson, who is retiring. Zaccardelli was most recently President and CEO of Dova Pharmaceuticals, which was acquired by Sobi in November 2019. The company also announced the appointment of Mark W. Hahn as Chief Financial … [Read more...] about Verona Pharma appoints David Zaccardelli as President and CEO